Cost-effectiveness analysis evaluates preventive interventions for respiratory syncytial virus in infants, suggesting improved health outcomes.
Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI; RSV-LRTI) among infants in Chile; young infants and infants born prematurely are at greatest risk.
No takes yet. Share an insight, caveat, or question.
Bolanos et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: